首页> 外文期刊>Malaria Journal >Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
【24h】

Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment

机译:蒿甲醚-荧光黄素或双氢青蒿素-哌喹治疗后,肯尼亚西部患有恶性疟原虫疟疾的儿童的配子清除率

获取原文
           

摘要

Abstract BackgroundThe efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya.MethodsChildren aged between 0.5 and 12?years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment. A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6?weeks after treatment during the peak malaria transmission season in 2016 and preserved. Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined.ResultsAt baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.7% (253/302) children had gametocytes by RT-qPCR. Gametocyte prevalence by RT-qPCR decreased from 85.1% (126/148) at day 0 to 7.04% (5/71) at day 42 in AL group and from 82.4% (127/154) at day 0 to 14.5% (11/74) at day 42 in DP group. The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.5?days) than in the DP group (5.1?days) but not significantly different (p?=?0.301).ConclusionThe study identifies no significant difference between AL and DP in gametocyte clearance. Gametocytes persisted up to 42?days post treatment in minority of individuals in both treatment arms. A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently.
机译:摘要背景已有文献记载了蒿甲醚-荧光粉(AL)和双氢青蒿素-哌喹(DP)对无性寄生虫种群的有效性和安全性。但是,这些抗疟疾对性寄生虫的作用仍不清楚。治疗后清除配子细胞对于控制和消除疟疾至关重要。因此,该研究试图确定肯尼亚疟疾流行地区儿童经AL或DP治疗后配子清除率的变化趋势。方法将肯尼亚西部Busia 0.5至12岁,无复杂性恶性疟原虫疟疾的儿童随机分配至AL或DP治疗。共有334名儿童入组,在2016年疟疾传播高峰期,在治疗后长达6周的时间内收集了干血斑样本并保存了下来。通过qRT-PCR检测恶性疟原虫配子细胞,并测定配子细胞的流行率,密度和平均配子持续时间。结果在基线时,所有334名儿童的无性寄生虫呈阳性,经镜检可检测到12%(40/334)的配子细胞, RT-qPCR检测发现有83.7%(253/302)儿童的配子细胞。 RT组的配子细胞流行率从第0天的85.1%(126/148)降至第42天的7.04%(5/71),从第0天的82.4%(127/154)降至14.5%(11 / 74)在DP组中的第42天。经qRT-PCR估计,AL组(4.5?天)的平均配子细胞运输持续时间略短于DP组(5.1?天),但差异无统计学意义(p?=?0.301)。 AL和DP在配子细胞清除率上的显着差异。在两个治疗组中,少数个体中的配子细胞在治疗后持续长达42天。杀配杀虫剂药物与基于青蒿素的联合治疗相结合,将有助于更有效地阻断疟疾的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号